Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effects of Beta-Carotene Fortified Synbiotic Food on Metabolic Control of Patients With Type 2 Diabetes Mellitus: A Double-Blind Randomized Cross-Over Controlled Clinical Trial Publisher Pubmed



Asemi Z1 ; Alizadeh SA2 ; Ahmad K3 ; Goli M4 ; Esmaillzadeh A5, 6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran
  2. 2. Department of Research and Development of Sekkeh Gaz Company, Isfahan, Iran
  3. 3. Department of Microbiology, Kashan University of Medical Sciences, Kashan, Iran
  4. 4. Department of Food Science and Technology, Islamic Azad University, Khorasgan Branch, Khorasgan, Iran
  5. 5. Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Clinical Nutrition Published:2016


Abstract

Background & aims: The aim of the present study was to determine the beneficial effects of beta-carotene fortified synbiotic food intake on metabolic status in patients with type 2 diabetes mellitus (T2DM). Methods: This randomized double-blinded placebo-controlled crossover clinical trial was conducted among 51 patients with T2DM. Individuals were randomly assigned to take either a beta-carotene fortified synbiotic (n = 51) or control food (n = 51) for 6 weeks. The beta-carotene fortified synbiotic was containing Lactobacillus sporogenes (1 × 107 CFU), 0.1 g inulin and 0.05 g beta-carotene. Control food (the same substance without probiotic, inulin and beta-carotene) was packed in identical 9-g packages. Patients were requested to use the beta-carotene fortified synbiotic and control foods three times a day. Results: Beta-carotene fortified synbiotic food consumption resulted in a significant decrease in insulin (-1.00 ± 7.90 vs. +3.68 ± 6.91 μIU/mL, P = 0.002), HOMA-IR (-0.73 ± 3.96 vs. +1.82 ± vbnm4.09, P = 0.002), HOMA-B (-0.52 ± 19.75 vs. +8.71 ± 17.15, P = 0.01), triglycerides (-2.86 ± 49.53 vs. +20.14 ± 50.10 mg/dL, P = 0.02), VLDL-cholesterol levels (-0.57 ± 9.90 vs. +4.03 ± 10.02 mg/dL, P = 0.02) and total-/HDL-cholesterol ratio (-0.01 ± 1.08 vs. +0.64 ± 0.81, P = 0.001) compared to the control food. In addition, beta-carotene fortified synbiotic food consumption led to elevated plasma nitric oxide (NO) (+6.83 ± 16.14 vs. -3.76 ± 16.47 μmol/L, P = 0.001) and glutathione (GSH) (+36.58 ± 296.71 vs. -92.04 ± 243.05 μmol/L, P = 0.01). Conclusions: Beta-carotene fortified synbiotic food intake in patients with T2DM for 6 weeks had favorable effects on insulin, HOMA-IR, HOMA-B, triglycerides, VLDL-cholesterol, total-/HDL-cholesterol ratio, NO and GSH levels. © 2015 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism.
Experts (# of related papers)
Other Related Docs
18. Effect of Fenugreek Seeds on Blood Glucose and Lipid Profiles in Type 2 Diabetic Patients, International Journal for Vitamin and Nutrition Research (2009)
20. Association Between High Doses Consumption of Niacin and Type 2 Diabetes, Journal of Babol University of Medical Sciences (2012)
22. Brewer's Yeast Improves Glycemic Indices in Type 2 Diabetes Mellitus, International Journal of Preventive Medicine (2013)
33. Long Term Effects of Oral Vitamin E Supplement in Type Ii Diabetic Patients, International Journal for Vitamin and Nutrition Research (2005)
43. Sugar-Sweetened Beverages Consumption Is Associated With Abdominal Obesity Risk in Diabetic Patients, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2017)